Cboe Global Markets, Inc. (CBOE) is one of the world's largest derivatives and securities exchange operators. Founded in 1973 and headquartered in Chicago, the company runs the largest options exchange in the United States, which contributes roughly 60% of its revenue, and is best known for its proprietary S&P 500 (SPX) and VIX index options. It also operates cash equities, futures, global foreign exchange, and a growing digital-assets business.
The $400 question reflects how far CBOE shares have already traveled. The stock set a 52-week high of $371.18 in May 2026 before pulling back, and it has traded in a range between roughly $227 and $371 over the past year. Because $371 now stands as the major prior peak, the next clean psychological milestone for the shares is $400. Reaching that level would require the stock not only to reclaim its record high but to extend decisively beyond it.
In recent sessions, shares have been changing hands near the $307 level, with a market capitalization of roughly $32 billion. The stock trades at a trailing price-to-earnings (P/E) ratio in the low-to-mid 20s on earnings per share of about $12.90, and it pays a dividend yielding approximately 1%. From around $307, a move to $400 would represent upside of about 30%.
CBOE has posted record results that give the bull case real substance. In the second quarter of 2026, the company reported record net revenue of roughly $732 million, driven by a 30% surge in derivatives-segment revenue, while its operating margin expanded to about 65%. Management has also raised its organic revenue guidance into the low double-digit to mid-teens range.
Cost discipline adds another tailwind. A 20% workforce reduction and the planned sale of the Canada and Australia businesses are expected to deliver $100 million to $120 million in total expense savings, partially offset by lost revenue. Meanwhile, new initiatives — including a planned Mini S&P 500 prediction-market contract, a CNBC studio partnership, expanded market-data (Data Vantage) offerings, and bitcoin-related volatility products — give the company fresh revenue channels beyond its core options franchise.
Competition is the clearest headwind. The rise of prediction-market platforms such as Polymarket, which has sought regulatory approval, and the CFTC's approval of bitcoin perpetual futures for rival venues have pressured exchange valuations and raise questions about whether CBOE can defend its fee structure. The company's results also remain tied to trading volumes and volatility, which can normalize quickly.
Valuation is a separate concern. Several research providers and at least one major bank (Goldman Sachs, which maintains a Sell rating) have characterized the stock as overvalued relative to fair-value estimates, arguing that current multiples already price in strong execution and leave limited margin of safety.
The Wall Street consensus is far more cautious than a $400 objective. The average analyst price target is approximately $315, with a consensus "Hold" rating. Targets span from a low of about $258 to a high near $356, with recent adjustments including Barclays raising its target toward $354 and TD Cowen to $315, while UBS sits near $335. Because even the most bullish published targets remain below $400, achieving that level would require the company to outperform expectations and persuade the market to assign a higher multiple.
From a technical analysis perspective, the prior all-time high of $371.18 is the dominant resistance level that must be reclaimed before $400 enters reach. On the downside, the $300 mark and the $284–$290 zone that held during the recent pullback represent key support levels investors are likely to watch. A decisive break above $371 would put the psychological $400 level in play, while a failure to hold $300 would argue against near-term upside.
Tracking whether CBOE can build toward a target like $400 requires monitoring changing technical behavior and market conditions in real time. Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting technical behavior and AI-driven analysis. Traders can use these signals to discover new opportunities, monitor existing positions, and identify changing market trends more efficiently. For those following CBOE and similar securities, these tools offer a data-driven way to stay ahead of evolving price action.
A move to $400 appears ambitious but not impossible. The strongest supporting factors are record revenue, expanding margins, disciplined cost control, and a pipeline of new products that could broaden the company's addressable market. The primary risks are intensifying competition, valuation that many analysts consider stretched, and a business model that relies heavily on sustained trading activity and volatility.
For $400 to become realistic, CBOE would likely need to reclaim its $371 high, sustain double-digit revenue growth across multiple quarters, and demonstrate that its prediction-market and data initiatives can offset competitive pressure. Investors should monitor earnings momentum, volume trends, regulatory developments in prediction markets and crypto derivatives, and whether the stock can hold support near $300. No outcome is guaranteed, and investors should weigh both the upside potential and the risks before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, CBOE has been loosely correlated with CME. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CBOE jumps, then CME could also see price increases.
| Ticker / NAME | Correlation To CBOE | 1D Price Change % | ||
|---|---|---|---|---|
| CBOE | 100% | -2.24% | ||
| CME - CBOE | 60% Loosely correlated | +0.54% | ||
| MKTX - CBOE | 29% Poorly correlated | -0.06% | ||
| TW - CBOE | 29% Poorly correlated | -1.01% | ||
| NDAQ - CBOE | 28% Poorly correlated | -0.56% | ||
| ICE - CBOE | 28% Poorly correlated | +1.02% | ||
More | ||||
| Ticker / NAME | Correlation To CBOE | 1D Price Change % |
|---|---|---|
| CBOE | 100% | -2.24% |
| Financial Publishing/Services industry (14 stocks) | 29% Poorly correlated | +0.63% |
| Commercial Services industry (91 stocks) | 9% Poorly correlated | +1.11% |